The objective of this course is to enhance understanding of the new paradigms of brain immunity and revisit the immune privilege concept to advance insights into crosstalk between immune components in health and disease, including brain tumors. Particular attention will be focused on immunosuppressive mediators and therapeutic targets in the tumor microenvironment of malignant gliomas. Ultimately, these knowledges could influence future screening and management of personalized cell therapies for patients affected by malignant gliomas.
Course Prerequisites
Basic knowledge of general immunology, SNC immunology, tumor immunology, tumor microenvironment, targeted therapies, immunotherapy
Teaching Methods
The course is organized in frontal lessons using Power Point presentations. The course will begin with an in-depth review of basic immunology. During the lessons, questions will be asked to verify basic knowledge and to verify the concepts of previous lessons step by step.
Assessment Methods
The final exam consists in a oral test on all the topics covered during the course. The rating scale is in thirtieths.
Texts
The course is not relying on a specific textbook. Lecture materials (including excerpts from available publications) will be provided to students.
Contents
The Course is built on knowledge pillars that will be address during the lectures: (i) general immunology and immunology of brain tumors; (ii) immune escape mechanisms; (iii) tumor microenvironment; (iv) new technologies applied to the tumor microenvironment; (v) Immunotherapy and Cell Therapy
Course Language
English
More information
For students with disabilities or DSA, student workers, students involved in caring for their family members, student parents, students at risk of dropping out, student athletes, the teacher will be available with meetings in person or through online platforms to meet the student's needs.
